[
    [
        {
            "time": "",
            "original_text": "四季度业绩有望继续向好，板块有望逐步渐入佳境-医药行业2019年业绩前瞻",
            "features": {
                "keywords": [
                    "四季度业绩",
                    "向好",
                    "医药行业",
                    "业绩前瞻"
                ],
                "sentiment_score": 0.8,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "四季度业绩有望继续向好，板块有望逐步渐入佳境-医药行业2019年业绩前瞻",
                "Correlation": 7,
                "Sentiment": 8,
                "Importance": 6,
                "Impact": 6,
                "Duration": 7,
                "Entity_Density": 5,
                "Market_Scope": 8,
                "Time_Proximity": 5,
                "Headline_Structure": 7,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "巨丰原创：2019年最牛的是科技股 2020年还可以牛下去吗？",
            "features": {
                "keywords": [
                    "科技股",
                    "2019年",
                    "2020年",
                    "牛市"
                ],
                "sentiment_score": 0.7,
                "policy_related": "false",
                "investment_strategy": "true",
                "sector_focus": [
                    "科技"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "巨丰原创：2019年最牛的是科技股 2020年还可以牛下去吗？",
                "Correlation": 6,
                "Sentiment": 7,
                "Importance": 7,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 4,
                "Market_Scope": 9,
                "Time_Proximity": 5,
                "Headline_Structure": 8,
                "Source_Recency": 6
            }
        },
        {
            "time": "",
            "original_text": "沪指稳守3000点春季攻势挺进纵深",
            "features": {
                "keywords": [
                    "沪指",
                    "3000点",
                    "春季攻势",
                    "挺进纵深"
                ],
                "sentiment_score": 0.6,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "沪指稳守3000点春季攻势挺进纵深",
                "Correlation": 5,
                "Sentiment": 7,
                "Importance": 8,
                "Impact": 7,
                "Duration": 6,
                "Entity_Density": 3,
                "Market_Scope": 10,
                "Time_Proximity": 6,
                "Headline_Structure": 7,
                "Source_Recency": 7
            }
        },
        {
            "time": "",
            "original_text": "生物药企Arcutis递交招股书，获恒瑞JAK抑制剂的海外授权",
            "features": {
                "keywords": [
                    "生物药企",
                    "Arcutis",
                    "招股书",
                    "恒瑞",
                    "JAK抑制剂",
                    "海外授权"
                ],
                "sentiment_score": 0.5,
                "policy_related": "false",
                "investment_strategy": "false",
                "sector_focus": [
                    "生物医药"
                ],
                "causal_factor": "true",
                "causal_impact": "positive",
                "affected_by_time_series": "true",
                "ts_effect_direction": "positive"
            },
            "scores": {
                "News_content": "生物药企Arcutis递交招股书，获恒瑞JAK抑制剂的海外授权",
                "Correlation": 9,
                "Sentiment": 9,
                "Importance": 9,
                "Impact": 8,
                "Duration": 8,
                "Entity_Density": 8,
                "Market_Scope": 6,
                "Time_Proximity": 7,
                "Headline_Structure": 8,
                "Source_Recency": 8
            }
        }
    ]
]